• Title/Summary/Keyword: Departments

Search Result 3,966, Processing Time 0.031 seconds

Large Focal Extrapleural Hematoma of Chest Wall: A Case Report

  • Lee, Hohyoung;Han, Sung Ho;Lee, Min Koo;Kwon, Oh Sang;Kim, Kyoung Hwan;Kim, Jung Suk;Chon, Soon-Ho;Shinn, Sung Ho
    • Journal of Trauma and Injury
    • /
    • v.32 no.2
    • /
    • pp.115-117
    • /
    • 2019
  • Although hemothorax and pneumothorax are common complications seen in rib fractures, focal extrapleural hematoma is quite rare. We report a 63-year-old female patient that developed large focal extrapleural hematoma after falling off a second floor veranda. The patient had sustained 3, 4, 5th costal cartilage rib fractures and a sternum fracture. She had developed suspected empyema with loculations with small amount of hemothorax. She underwent a planned early decortication/adhesiolysis by video assisted thoracoscopic surgery at the 12th post-trauma day due to failed drainage. Unexpectedly, she had no adhesions or any significant retained hematoma mimicking a mass, but was found with the focal extrapleural chest wall hematoma. She was discharged on postoperative 46th day for other reasons and is doing fine today.

Exercise-induced rhabdomyolysis with acute kidney injury complicated by posterior reversible encephalopathy syndrome: a case report

  • Kim, Su Min;Lee, Yoo Jin;Heo, Chang Min;Park, Si Hyung;Park, Kang Min;Ko, Jung Hae;Park, Bong Soo;Kim, Yang Wook
    • Annals of Clinical Neurophysiology
    • /
    • v.24 no.2
    • /
    • pp.93-97
    • /
    • 2022
  • Posterior reversible encephalopathy syndrome (PRES) is a rare condition manifested by inflammation in certain areas of the brain. Rhabdomyolysis with acute kidney injury (AKI) complicated by PRES is rarely reported. A 26-year-old female presented with neurological symptoms, high blood pressure, and AKI. Her symptoms improved with blood pressure control, anticonvulsant drug medications, and renal replacement therapy. This case demonstrates that PRES should be considered in the differential diagnosis of patients who have rhabdomyolysis with AKI accompanied by neurological symptoms, including headaches and convulsions.

Effects of Repeated Citalopram Treatments on Chronic Mild Stress-Induced Growth Associated Protein-43 mRNA Expression in Rat Hippocampus

  • Park, Sang-Ha;Choi, Song-Hyen;Lee, Ji-Min;Kang, Seung-Woo;Shin, You-Chan;Kim, Hyun-Ju;Kim, Hyun-Jung;Shin, Seung-Keon;Lee, Min-Soo;Shin, Kyung-Ho
    • The Korean Journal of Physiology and Pharmacology
    • /
    • v.12 no.3
    • /
    • pp.117-123
    • /
    • 2008
  • Although growth associated protein-43 (GAP-43) is known to playa significant role in the regulation of axonal growth and the formation of new neuronal connections in the hippocampus, there is only a few studies on the effects of acute stress on GAP-43 mRNA expression in the hippocampus. Moreover, the effects of repeated citalopram treatment on chronic mild stress (CMS)-induced changes in GAP-43 mRNA expression in the hippocampus have not been explored before. To explore this question, male rats were exposed to acute immobilization stress or CMS. Also, citalopram was given prior to stress everyday during CMS procedures. Acute immobilization stress significantly increased GAP-43 mRNA expression in all subfields of the hippocampus, while CMS significantly decreased GAP-43 mRNA expression in the dentate granule cell layer (GCL). Repeated citalopram treatment decreased GAP-43 mRNA expression in the GCL compared with unstressed controls, but this decrease was not further potentiated by CMS exposure. Similar decreases in GAP-43 mRNA expression were observed in CA1, CA3 and CA4 areas of the hippocampus only after repeated citalopram treatment in CMS-exposed rats. This result indicates that GAP-43 mRNA expression in the hippocampus may differently respond to acute and chronic stress, and that repeated citalopram treatment does not change CMS-induced decreases in GAP-43 mRNA expression in the GCL.

Gorham-Stout Syndrome with Focal Segmental Glomerulosclerosis: A Case Report

  • Kim, Ji Hyun;Kim, You Sun;Lim, Seon Hee;Ahn, Yo Han;Ko, Jung-Min;Suh, Dong In;Lee, Kyoung Bun;Moon, Kyung Chul;Ha, Il-Soo;Cheong, Hae Il;Kang, Hee Gyung
    • Childhood Kidney Diseases
    • /
    • v.24 no.2
    • /
    • pp.120-125
    • /
    • 2020
  • Gorham-Stout syndrome is a rare bone disorder characterized by progressive massive osteolysis and proliferation of vascular and lymphatic vessels. A 15-year-old boy was initially diagnosed with Gorham-Stout at the age of 8 years based on clinical and radiological findings. Following diagnosis, he was treated with pamidronate, interferon alfa, propranolol, oral corticosteroids, and sirolimus. He developed proteinuria at the age of 15 and progressed into the nephrotic range 2 years later. A renal biopsy revealed focal segmental glomerulosclerosis, not otherwise specified variant. The sequential increase in proteinuria associated with medications suggested that the focal segmental glomerulosclerosis may be caused by pamidronate and sirolimus, but cannot completely rule out the possibility of kidney involvement of GSS itself.

A Case of Small Cell Lung Cancer Coexisting with Chronic Lymphocytic Leukemia (만성 림프구성 백혈병이 동반된 소세포폐암 1예)

  • Song, June-Seok;Lee, Gun-Hwa;Lee, Min-Kyu;Kim, Woong-Jun;Lee, Seung-Ho;Kim, Sang-Heon;Kim, Tae-Hyung;Yoon, Ho-Joo;Shin, Dong-Ho;Park, Sung-Soo;Choi, Jung-Hye;Oh, Young-Ha;Sohn, Jang-Won
    • Tuberculosis and Respiratory Diseases
    • /
    • v.71 no.6
    • /
    • pp.454-458
    • /
    • 2011
  • Chronic lymphocytic leukemia (CLL) is the most common type of leukemia occurring in Western nations. In CLL it is well known that the risk of a secondary malignancy is higher than in the normal population. But in Korea, CLL is a rare type of leukemia, so there have been only a few reported cases with a secondary malignancy. CLL is characterized by progressive defects in both cell-mediated and humoral immunity. It is known that defects in the immune system of patients with CLL contribute to the development of a secondary malignancy. We experienced a case of a 71-year-old man who suffered from a chronic cough and was diagnosed with small cell lung cancer coexisting with CLL. Until this case, there was no reported case in Korea of small cell lung cancer coexisting with CLL. We now report a case of small cell lung cancer coexisting with CLL and present a literature review.

Effects of Curcumin on Osteoclasts (파골세포에 대한 커큐민의 효과)

  • Kim, Jeong-Joong;Kim, Dong-Joo;Lee, Byung-Ki;Kim, Kwang-Jin;Lee, Myeung-Su;Lee, Jae-Hoon;Kim, Hun-Soo;Lee, Chang-Hoon;Byun, Seung-Jae;Jang, Sung-Jo;Song, Jeong-Hoon;Oh, Jae-Min;Lee, Jun-Seok;Kim, Kwang-Mee;Chun, Churl-Hong
    • Journal of Physiology & Pathology in Korean Medicine
    • /
    • v.22 no.6
    • /
    • pp.1566-1571
    • /
    • 2008
  • Bone is a dynamic tissue that is constantly resorbed by osteoclasts and then replaced by osteoblasts. Osteoclasts, multinucleated cells of monocyte/macrophage lineage, are responsible for bone disorders, including osteoporosis and rheumatoid arthritis. In this study, we examined the effect of the curcumin on osteoclast survival and bone resorption. We found that curcumin significantly inhibited RANKL-mediated osteoclast survival. DAPI stainingrevealed that curcumin induced the apoptotic features of osteoclasts. Although curcumin did not suppress the phosphorylation of Akt and ERK in osteoclasts treated with RANKL, curcumin induced the cleavage of pro-caspase-9 and -3 its active forms. Also, curcumin inhibited the formation of actin rings of osteoclasts. RANKL-mediated bone resorption was inhibited by the addition of curcumin. Together with the results of this study, these findings suggest that the curcumin inhibited the survival of osteoclasts by activating caspase-9 and -3 and suppressed the bone resorptive activity. Thus, curcumin may be developed as antiresorptive drugs for the treatment of bone-related disorders.

Agrocybe chaxingu polysaccharide prevent inflammation through the inhibition of COX-2 and NO production

  • Lee, Byung-Ryong;Kim, So-Young;Kim, Dae-Won;An, Jae-Jin;Song, Ha-Yong;Yoo, Ki-Yeon;Kang, Tae-Cheon;Won, Moo-Ho;Lee, Kwang-Jae;Kim, Kyung-Hee;Joo, Jin-Ho;Ham, Hun-Ju;Hur, Jang-Hyun;Cho, Sung-Woo;Han, Kyu-Hyung;Lee, Kil-Soo;Park, Jin-Seu;Choi, Soo-Young;Eum, Won-Sik
    • BMB Reports
    • /
    • v.42 no.12
    • /
    • pp.794-799
    • /
    • 2009
  • The inhibition of nitric oxide (NO) and cyclooxygenase-2 (COX-2) production is considered to be a promising approach to the treatment of various diseases, including inflammation and cancer. In this study, we examined the effects of the Agrocybe chaxingu $\beta$-glucan (polysaccharide) on lipopolysaccaride (LPS)-induced nitric oxide (NO) and cyclooxygenase-2 (COX-2) expression in murine macrophage Raw 264.7 cells as well as 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced ear edema in mice. The polysaccharide significantly inhibited (P < 0.01) LPS-induced iNOS and COX-2 expression levels in the cells. Furthermore, topical application of polysaccharide resulted in markedly inhibited (P < 0.01) TPA-induced ear edema in mice. These results suggest that this polysaccharide may be used for NO- and COX-2-related disorders such as inflammation and cancer.

Expression Pattern of Caspase 2 in Korean Gastric Cancers (한국인 위암에서 Caspase 2 단백 발현 양상)

  • Kim, Chang-Jae;Park, Jik-Young;Lee, Jong-Heun;Cho, Young-Gu;Lee, Jong-Woo;Song, Young-Hwa;Kim, Young-Sil;Park, Cho, Hyun;Nam, Suk-Woo;Lee, Sug-Hyung;Yoo-Nam-Jin;Park, Won-Sang;Lee, Jung, Young
    • Journal of Gastric Cancer
    • /
    • v.3 no.1
    • /
    • pp.38-43
    • /
    • 2003
  • Purpose: Caspase 2, a member of the family of ICE-like proteases, is activated by the Fas pathway and induces apoptosis by triggering the caspase cascade. The purpose of this study was to determine whether the expression pattern of caspase 2 might be associated with gastric cancer development and if so, to determine to which pathologic parameter it is linked. Materials and Methods: For the construction of the gastric cancer tissue microarray, 78 paraffin-embedded tissues containing gastric cancer areas were cored 3 times and transferred to the recipient master block. The expression pattern of caspase 2 was examined on tissue microarray slides by using immunohistochemistry and was compared with pathologic parameters, including histologic type, depth of invasion, lymph node metastasis, and peritoneal dissemination. Results: Caspase 2 was expressed on superficial and foveolar epithelial cells and lymphocytes in the gastric mucosa, mainly in cytoplasm. We found loss of caspase 2 expression in 41 ($52.6\%$) of the 78 gastric cancer tissues. Statistically, histologic type and other pathologic parameters were not related with loss of caspase 2 expression Conclusion: Our findings provide enough evidence that loss of caspase 2 expression may contribute to the development of Korean gastric cancer and that it might be one of the possible escape mechanisms from apoptosis in gastric cancer.

  • PDF

The Role of Preoperative Chemotherapy in Patients with Inoperable Metastatic or Locally Advanced Gastric Cancer (수술이 불가능한 전이성 또는 국소 진행성 위암 환자에서 선행화학요법의 효과)

  • Chung Yoo-Seung;Park Do Joong;Lee Hyuk-Joon;Kim Se Hyung;Han Joon Koo;Kim Tae-You;Bang Yung-Jue;Heo Dae Seog;Kim No Kyung;Kim Woo Ho;Yang Han-Kwang;Lee Kuhn Uk;Choe Kuk Jin
    • Journal of Gastric Cancer
    • /
    • v.4 no.1
    • /
    • pp.7-14
    • /
    • 2004
  • Purpose: The purpose of this study was to evaluate the treatment result of surgical resection after preoperative chemotherapy in inoperable gastric cancer patients. Materials and Methods: We analyzed 18 gastric cancer patients who underwent gastric resection after preoperative chemotherapy because they showed some clinical response to chemotherapy (15 with distant metastasis and 3 with locally advanced lesions). The mean postoperative follow-up period was $15.3\pm15.5$ ($1\∼56$) months. Results: In 15 patients with distant metastasis, 2 ($13.3\%$) showed complete response (CR), 10 ($66.7\%$) partial response (PR), 2 ($13.3\%$) stable disease (SD), and 1 ($6.7\%$) progressive disease (PD). The clinical response rate was $80.0\%$ Five subtotal gastrectomies, 4 total gastrectomies, and 6 extended total gastrectomies were performed. Two cases of CR were alive without recurrence for 4 and 26 months, respectively. Mean survival period in PR case was 37.7 months, but 2 cases of SD and 1 case of PD died after 11.7, 17.9, and 0.9 months, respectively. Postoperative survival was significantly associated with the response to chemotherapy (P<0.01). The mean survival period of the 10 patients with a complete resection was 44.1 months, which was significantly better than that of the 5 patients with an incomplete resection (9.8 months, P=0.03). Among 3 patients with locally advanced gastric cancer, 2 cases showed PR to chemotherapy, and complete resection was possible only by gastrectomy for those patients. Conclusion: In some selected cases, surgical resection was achievable after preoperative chemotherapy for patients with inoperable metastatic or locally advanced gastric cancer.

  • PDF

Metastatic Carcinoma of an Unknown Primary Site Presented to the Neck (경부 림프절 종대로 발현한 원발 부위 불명의 전이암)

  • Kim Tae-Yong;Joh Yo-Han;Kim Jin-Su;Hong Yong-Sang;Lee Keun-Wook;Yun Tak;Song Eun-Ki;Na Im-Il;Shin Hyun-Chun;Kim Dong-Wan;Rlee Chae-Seo;Sung Myung-Whun;Heo Dae-Seog
    • Korean Journal of Head & Neck Oncology
    • /
    • v.20 no.2
    • /
    • pp.181-188
    • /
    • 2004
  • Background: About 3% of all cancer patients suffer from cancer of unknown primary origin. Generally, carcinoma of unknown primary (CUP) carries a grave prognosis, but primary tumor presented to the neck is exception to this. The aims of study are to determine the role of chemotherapy and to find the prognostic factors in unknown primary tumor presented to the neck. Method and Material: Eighty-four patients were diagnosed with unknown primary tumor presented to the neck between January 1996 and June 2002. Among 84 patients, 43 patients (52%) received chemotherapy, radiation or surgery were performed in 20 patients (23%), 21 patients (25%) had no treatment. Results: The response rates to chemotherapy were 87.5% in CUP only localized to the neck and 44.0% in CUP systemically involved (p=0.012). A median follow-up duration was 6.4 years and overall median survival time was 9 months. The median overall survival time of patients treated with chemotherapy were 17 months and that of patients who received surgery or radiation were 20 months (p=0.3548). The important prognostic factors were performance status and the number of involved organ. Conclusion: The prognosis of patients with CUP presented to the neck is more favorable than that of patients with CUP of other localization. The effectiveness of chemotherapy for CUP only localized to the neck was similar to that of surgery or radiation. The important prognostic factors were performance status and the number of involved organ.